Table 1 Patient characteristics
Age | Primary | Extra | K-Ras mut | UGT1A1 | Previous chemotherapy hepatic lesions |
|---|---|---|---|---|---|
1. 60 | S | Lung | − | Wild | 5FU, L-OHP, CPT-11 anti-VEGF/EGFR Ab |
2. 71 | D | − | Homo | 5FU, L-OHP, anti-VEGF/EGFR Ab | |
3. 69 | D | + | Wild | 5FU, L-OHP, CPT-11, Anti-VEGF Ab | |
4. 63 | T | Peritoneum | − | Wild | 5FU, L-OHP, CPT-11, anti-VEGF/EGFR Ab |
5. 55 | R | + | Wild | 5FU, L-OHP, CPT-11, anti-VEGF Ab | |
6. 81 | C | Bone | + | Hetero | 5FU, L-OHP |
7. 55 | R | Lung | − | Hetero | 5FU, L-OHP, CPT-11, anti-VEGF Ab |
8. 56 | D | Lung | − | Hetero | 5FU, L-OHP, CPT-11, anti-VEGF/EGFR Ab |
9. 56 | R | − | Wild | 5FU, L-OHP, CPT-11, anti-VEGF Ab | |
10. 57 | R | − | Wild | 5FU, L-OHP, CPT-11, anti-VEGF/EGFR Ab |